Clicky

Dr. Reddy's Laboratories Ltd(RDY)

Description: Dr. Reddy's Laboratories Limited operates as an integrated pharmaceutical company. It operates in three segments: Pharmaceutical services and Active Ingredients (PSAI), Global Generics, and Proprietary Products. The PSAI segment develops active pharmaceutical ingredients (APIs) and intermediaries, which are used as principal ingredients for finished pharmaceutical products. This segment also offers contract research services to biotech and pharmaceutical companies; and manufactures and sells APIs and steroids in accordance with the specific customer requirements. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment also engages in the operation of biologics business. The Proprietary Products segment engages in the discovery and development of new chemical entities for subsequent commercialization and out-licensing. It offers new, synergistic combination, and technology formulations that modifies pharmacokinetics of existing medicines. This segment is also involved in the Company's specialty pharmaceuticals business that includes sales and marketing operations for in-licensed and co-developed dermatology. The company offers its products and services primarily in the areas of gastrointestinal, cardiovascular, pain management, and oncology therapies. It primarily operates in India, the United States, Russia and other countries of the former Soviet Union, Europe, and others. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.


Keywords: Pharmaceutical Pharmaceutical Products Active Pharmaceutical Ingredients Pain Management Dermatology Gastrointestinal Pharmacokinetics Pharmaceutical Industry In India Contract Research Services Oncology Therapies Chemical Entities Pharmaceutical Services Dr. Reddy's Laboratories Biotech And Pharmaceutical

Home Page: www.drreddys.com

RDY Technical Analysis

8-2-337, Road No. 3
Hyderabad, 500034
India
Phone: 91 40 4900 2900


Officers

Name Title
Mr. Gunupati Venkateswara Prasad B.E. Co-Chairman, MD & Member of Management Council
Mr. Kallam Satish Reddy B.Tech., M.S. Chairman & Member of the Management Council
Mr. Erez Israeli M.B.A. CEO & Member of the Management Council
Mr. Parag Agarwal CFO & Member of Management Council
Mr. Deepak Sapra M.B.A. CEO of API & Services & Member of Management Council
Mr. Venkata Ramana Motupalli M.B.A., MBA CEO of Branded Markets - India & Emerging Countries and Member of Management Council
Ms. Archana Bhaskar B.Sc., M.B.A. EVP, Head of Corp. Communications, Chief HR Officer & Member of Management Council
Mr. Sanjay Sharma B.Tech. Exec. VP, Global Head of Global Manufacturing & Member of Management Council
Mr. Marc Kikuchi B.A., M.B.A. CEO of North America Generics & Member of Management Council
Mr. Patrick Aghanian B.A., M.B.A. CEO of European Generics & Member of Management Council

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 20.7039
Trailing PE: 23.6144
Price-to-Book MRQ: 3.6523
Price-to-Sales TTM: 0.039
IPO Date: 2001-04-11
Fiscal Year End: March
Full Time Employees: 24795
Back to stocks